Ipca Laboratories
₹1,965.30
30
+₹9.20+0.47% Friday 09:59
Statistics
Day High
1,969
Day Low
1,944.2
52W High
2,001.5
52W Low
1,251.6
Volume
80,401
Avg. Volume
393,222
Mkt Cap
498.6B
P/E Ratio
40.46
Dividend Yield
0.31%
Dividend
6
Upcoming
Dividends
0.31%Dividend Yield
Sep 26
₹6.00
Aug 25
₹2.00
Dec 24
₹2.00
Aug 24
₹2.00
Dec 23
₹2.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
9NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
8.73
11.15
13.56
15.98
Expected EPS
13.997433487799999
Actual EPS
N/A
Financials
11.93%Profit Margin
Profitable95.63BRevenue
11.41BNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow IPCALAB.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Show more...
CEO
Pranay Premchand Godha
Employees
17210
Country
India
ISIN
INE571A01038
Listings
0 Comments
Share your thoughts
FAQ
What is Ipca Laboratories stock price today?▼
The current price of IPCALAB.NSE is ₹1,965.30 INR — it has increased by +0.47% in the past 24 hours. Watch Ipca Laboratories stock price performance more closely on the chart.
What is Ipca Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Ipca Laboratories stocks are traded under the ticker IPCALAB.NSE.
Is Ipca Laboratories stock price growing?▼
IPCALAB.NSE stock has risen by +0.77% compared to the previous week, the month change is a +10.53% rise, over the last year Ipca Laboratories has showed a +47.24% increase.
What is Ipca Laboratories market cap?▼
Today Ipca Laboratories has the market capitalization of 498.6B
When is the next Ipca Laboratories earnings date?▼
Ipca Laboratories is going to release the next earnings report on November 09, 2026.
What were Ipca Laboratories earnings last quarter?▼
IPCALAB.NSE earnings for the last quarter are 15.98 INR per share, whereas the estimation was 12.27 INR resulting in a +30.25% surprise. The estimated earnings for the next quarter are N/A INR per share.
What is Ipca Laboratories revenue for the last year?▼
Ipca Laboratories revenue for the last year amounts to 95.63B INR.
What is Ipca Laboratories net income for the last year?▼
IPCALAB.NSE net income for the last year is 11.41B INR.
Does Ipca Laboratories pay dividends?▼
Yes, IPCALAB.NSE dividends are paid annual. The last dividend per share was 2 INR. As of today, Dividend Yield (FWD)% is 0.31%.
How many employees does Ipca Laboratories have?▼
As of September 05, 2026, the company has 17,210 employees.
In which sector is Ipca Laboratories located?▼
Ipca Laboratories operates in the Health & Wellness sector.
When did Ipca Laboratories complete a stock split?▼
The last stock split for Ipca Laboratories was on January 10, 2022 with a ratio of 2:1.
Where is Ipca Laboratories headquartered?▼
Ipca Laboratories is headquartered in Mumbai, India.